Mission

The goals of the Molecular Imaging (MI) Program include the development and testing of new imaging methods ranging from preclinical work on the synthesis of new probes and development of new devices to the clinical evaluation of imaging approaches to assess cancer risk, detect cancer, guide treatment and monitor therapy. These imaging methods are aimed at improving our understanding of cancer physiology and providing for the integration of these findings to ultimately improve the assessment of cancer and its treatment. To achieve these goals we have two themes. 

Scientific Themes

  • Theme 1. Synthesis of new imaging agents for metabolism and drug pharmacodynamics
  • Theme 2. Implement and test new imaging agents and methods for risk assessment, detection, guidance and assessment of the response to therapy
  • Theme 3. Develop and test novel instrumentation for molecular imaging

Program Activities

The MI Program works to bring investigators together to expand collaborative activities with members of our program and other programs through:

  • Monthly program meetings which include speakers from within the MI Program, speakers from related disciplines and invited outside speakers. 
  • Joint meetings or mini-retreats with other programs to highlight particular areas of collaboration. 
  • Yearly retreats are held for the program to further foster collaboration among members
  • Organization of working groups to evaluate joint projects including multi-investigator pilot projects, protocols, and grants. 

Program Leaders

  • Nerissa Viola, Ph.D.

    Leader, Molecular Imaging Program
    Karmanos Cancer Institute
    Wayne State University School of Medicine

  • Anthony Shields, M.D., Ph.D.

    Co-Leader, Molecular Imaging Program
    Karmanos Cancer Institute
    Wayne State University School of Medicine

The Latest From Karmanos Cancer Institute

News

IN THE NEWS: Cancer Researcher Highlights ‘Myths and Misconceptions’ Patients Have About Trials

Healio Do you understand how clinical trials work in oncology? Wasif Saif, M.D., MBBS , medical oncologist, leader of the  Phase I Clinical T...

Read More

Stomach Cancer: The Cancer Affecting Over 26,000 People This Year

Though rare in the U.S., stomach cancer makes up about 1.5% of all cancer diagnoses annually. The American Cancer Society estimates that over 26,8...

Read More

IN THE NEWS: Breast Cancer Community Finds Safe Haven on Reddit

WebMD Breast cancer survivors have turned the in-person support group into a thread on Reddit. Researchers at the University of Colorado Anschutz ...

Read More
News

101 WRIF | Lung Cancer Awareness

Listen Now

Becker’s Healthcare Podcast | Exploring Breakthroughs in Cancer Treatment with Dr. Boris C. Pasche, President & CEO at Karmanos Cancer Institute

Listen Now

WWJ | Karmanos Cancer Institute Hosts Classic Cars for the Cure

Listen Now